D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| 1 |
NVIDIA
NVDA
|
+$1.27B |
| 2 |
Meta Platforms (Facebook)
META
|
+$728M |
| 3 |
Microsoft
MSFT
|
+$524M |
| 4 |
T-Mobile US
TMUS
|
+$411M |
| 5 |
Uber
UBER
|
+$406M |
Top Sells
| 1 |
Visa
V
|
+$567M |
| 2 |
Charles Schwab
SCHW
|
+$531M |
| 3 |
Apple
AAPL
|
+$484M |
| 4 |
Johnson & Johnson
JNJ
|
+$455M |
| 5 |
Accenture
ACN
|
+$401M |
Sector Composition
| 1 | Technology | 25.5% |
| 2 | Consumer Discretionary | 13.42% |
| 3 | Healthcare | 12.98% |
| 4 | Financials | 9.15% |
| 5 | Industrials | 7.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
451
Arch Capital
ACGL
$33.8B
| $22.8M | 0.02% |
305,237
+24,510
| +9% | +$1.83M |
|
452
Trane Technologies
TT
$92.9B
| $22.8M | 0.02% |
119,319
-18,139
| -13% | -$3.47M |
|
453
Neurocrine Biosciences
NBIX
$14B
| $22.7M | 0.02% |
240,484
+61,378
| +34% | +$5.79M |
|
454
Qualys
QLYS
$4.75B
| $22.6M | 0.02% |
175,322
-3,657
| -2% | -$472K |
|
455
Vita Coco
COCO
$2.19B
| $22.5M | 0.02% |
836,276
+562,606
| +206% | +$15.1M |
|
456
Genpact
G
$7.49B
| $22.3M | 0.02% |
+593,957
| New | +$22.3M |
|
457
Travelers Companies
TRV
$61.3B
| $22.2M | 0.02% |
127,969
+77,533
| +154% | +$13.5M |
|
458
Sempra
SRE
$53.5B
| $22.2M | 0.02% |
305,158
+108,498
| +55% | +$7.9M |
|
459
Q2 Holdings
QTWO
$5.13B
| $22.2M | 0.02% |
717,922
+24,626
| +4% | +$761K |
|
460
AMN Healthcare
AMN
$751M
| $21.9M | 0.02% |
200,961
-189,330
| -49% | -$20.7M |
|
461
Fate Therapeutics
FATE
$115M
| $21.9M | 0.02% |
4,599,439
+1,634,197
| +55% | +$7.78M |
|
462
Morgan Stanley
MS
$246B
| $21.9M | 0.02% |
256,283
+9,823
| +4% | +$839K |
|
463
Akamai
AKAM
$11B
| $21.9M | 0.02% |
243,397
-177,158
| -42% | -$15.9M |
|
464
FMC
FMC
$4.61B
| $21.7M | 0.02% |
208,345
+99,741
| +92% | +$10.4M |
|
465
Acushnet Holdings
GOLF
$4.37B
| $21.7M | 0.02% |
397,222
-47,052
| -11% | -$2.57M |
|
466
Scorpio Tankers
STNG
$2.92B
| $21.6M | 0.02% |
457,351
-288,957
| -39% | -$13.6M |
|
467
Enviri
NVRI
$959M
| $21.5M | 0.02% |
2,182,086
+59,768
| +3% | +$590K |
|
468
Monolithic Power Systems
MPWR
$41B
| $21.5M | 0.02% |
39,771
-81,762
| -67% | -$44.2M |
|
469
Aflac
AFL
$57.3B
| $21.5M | 0.02% |
307,757
+115,099
| +60% | +$8.03M |
|
470
Clear Secure
YOU
$3.48B
| $21.4M | 0.02% |
921,686
+3,538
| +0.4% | +$82K |
|
471
Alkermes
ALKS
$4.45B
| $21.3M | 0.02% |
681,619
+237,339
| +53% | +$7.43M |
|
|
SAGE
472
DELISTED
Sage Therapeutics
SAGE
| $21.2M | 0.02% |
451,272
+3,037
| +0.7% | +$143K |
|
473
F5
FFIV
$18.8B
| $21.2M | 0.02% |
144,893
-26,835
| -16% | -$3.92M |
|
474
HDFC Bank
HDB
$180B
| $21.1M | 0.02% |
+302,654
| New | +$21.1M |
|
475
Bread Financial
BFH
$2.99B
| $21.1M | 0.02% |
671,488
+218,050
| +48% | +$6.84M |
|